217 related articles for article (PubMed ID: 22227921)
1. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.
Lal G; Groff M; Howe JR; Weigel RJ; Sugg SL; Lynch CF
Ann Surg Oncol; 2012 Jun; 19(6):1887-96. PubMed ID: 22227921
[TBL] [Abstract][Full Text] [Related]
2. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
3. Risk of thyroid cancer after therapeutic irradiation in adult patients: An Age-Based surveillance, epidemiology, and end results analysis.
Dalwadi SM; Dorman C; Fisher SB; Bonnen M; Grubbs E; Ludwig MS
Laryngoscope; 2020 Aug; 130(8):2081-2086. PubMed ID: 31747075
[TBL] [Abstract][Full Text] [Related]
4. Risk of second primary thyroid cancer in cancer survivors.
Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
6. Risk of thyroid malignancy following an index head and neck squamous cell carcinoma: A population-based study.
Chan JY; Gooi Z; Mydlarz WK; Agrawal N
Ear Nose Throat J; 2016 Dec; 95(12):E7-E11. PubMed ID: 27929600
[TBL] [Abstract][Full Text] [Related]
7. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
8. Coupling of prostate and thyroid cancer diagnoses in the United States.
Tomaszewski JJ; Uzzo RG; Egleston B; Corcoran AT; Mehrazin R; Geynisman DM; Ridge JA; Veloski C; Kocher N; Smaldone MC; Kutikov A
Ann Surg Oncol; 2015 Mar; 22(3):1043-9. PubMed ID: 25205302
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
[TBL] [Abstract][Full Text] [Related]
10. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
11. Incidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study.
Mao K; Jiang W; Liu J; Wang J
Medicine (Baltimore); 2015 Feb; 94(8):e596. PubMed ID: 25715268
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
13. Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer.
Polednik KM; Simpson MC; Adjei Boakye E; Mohammed KA; J Dombrowski J; Varvares MA; Osazuwa-Peters N
Laryngoscope; 2019 Apr; 129(4):1014-1020. PubMed ID: 30208210
[TBL] [Abstract][Full Text] [Related]
14. Risk of subsequent cancer following a primary CNS tumor.
Strodtbeck K; Sloan A; Rogers L; Fisher PG; Stearns D; Campbell L; Barnholtz-Sloan J
J Neurooncol; 2013 Apr; 112(2):285-95. PubMed ID: 23392847
[TBL] [Abstract][Full Text] [Related]
15. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.
Kim C; Bi X; Pan D; Chen Y; Carling T; Ma S; Udelsman R; Zhang Y
Thyroid; 2013 May; 23(5):575-82. PubMed ID: 23237308
[TBL] [Abstract][Full Text] [Related]
16. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
17. Risk of second malignancies among survivors of pediatric thyroid cancer.
Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
[TBL] [Abstract][Full Text] [Related]
18. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
19. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Bassal M; Mertens AC; Taylor L; Neglia JP; Greffe BS; Hammond S; Ronckers CM; Friedman DL; Stovall M; Yasui YY; Robison LL; Meadows AT; Kadan-Lottick NS
J Clin Oncol; 2006 Jan; 24(3):476-83. PubMed ID: 16421424
[TBL] [Abstract][Full Text] [Related]
20. The association between histological subtype of a first primary endometrial cancer and second cancer risk.
Rhoades J; Vetter MH; Fisher JL; Cohn DE; Salani R; Felix AS
Int J Gynecol Cancer; 2019 Feb; 29(2):290-298. PubMed ID: 30718311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
